Kevin Kalinsky, MD, MS, is Professor of Hematology and Medical Oncology at Emory University, Director of Medical Oncology, and leader of the Glenn Family Breast Center at Winship Cancer Institute. A breast cancer specialist, he conducts clinical trials for early- and advanced-stage disease, focusing on genomics-driven, personalized therapies, and has led pivotal studies such as RxPONDER.